{"entity":{"type":"insider","cik":"0001558362","url":"/insider/0001558362","json_url":"/insider/0001558362.json","name":"Midler Andrew R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":1,"first":"2015-02-12","last":"2015-02-12","span_basis":"filed_date"},"name_variants":[{"name":"Midler Andrew R","source":"filing","n_filings":1,"first_seen":"2015-02-12","last_seen":"2015-02-12"}],"transactions":[{"id":8258278,"accession":"0001426812-15-000001","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001426812-15-000001","line_url":"/filing/0001426812-15-000001#line-11","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":null,"owner_name":"SPCH, LLC; Midler Andrew R","owner_display_name":"SPCH, LLC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":9.33,"price_display":"9.33","price_state":"stated","total_value":9330.0,"total_display":"9,330.00","total_whole":"9,330","shares_owned_after":79238.0,"shares_owned_after_display":"79,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-19","filed_date":"2015-02-12","scope":"insider"},{"id":8258274,"accession":"0001426812-15-000001","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001426812-15-000001","line_url":"/filing/0001426812-15-000001#line-10","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":null,"owner_name":"SPCH, LLC; Midler Andrew R","owner_display_name":"SPCH, LLC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":8.7433,"price_display":"8.74","price_state":"stated","total_value":17486.6,"total_display":"17,486.60","total_whole":"17,487","shares_owned_after":79238.0,"shares_owned_after_display":"79,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-29","filed_date":"2015-02-12","scope":"insider"},{"id":8258270,"accession":"0001426812-15-000001","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001426812-15-000001","line_url":"/filing/0001426812-15-000001#line-9","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":null,"owner_name":"SPCH, LLC; Midler Andrew R","owner_display_name":"SPCH, LLC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":9.07,"price_display":"9.07","price_state":"stated","total_value":9070.0,"total_display":"9,070.00","total_whole":"9,070","shares_owned_after":79238.0,"shares_owned_after_display":"79,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-19","filed_date":"2015-02-12","scope":"insider"},{"id":8258266,"accession":"0001426812-15-000001","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001426812-15-000001","line_url":"/filing/0001426812-15-000001#line-8","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":null,"owner_name":"SPCH, LLC; Midler Andrew R","owner_display_name":"SPCH, LLC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":9.2848,"price_display":"9.28","price_state":"stated","total_value":9284.8,"total_display":"9,284.80","total_whole":"9,285","shares_owned_after":79238.0,"shares_owned_after_display":"79,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-07-31","filed_date":"2015-02-12","scope":"insider"},{"id":8258264,"accession":"0001426812-15-000001","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001426812-15-000001","line_url":"/filing/0001426812-15-000001#line-7","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":null,"owner_name":"SPCH, LLC; Midler Andrew R","owner_display_name":"SPCH, LLC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":9.3155,"price_display":"9.32","price_state":"stated","total_value":9315.5,"total_display":"9,315.50","total_whole":"9,316","shares_owned_after":79238.0,"shares_owned_after_display":"79,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-07-30","filed_date":"2015-02-12","scope":"insider"},{"id":8258260,"accession":"0001426812-15-000001","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001426812-15-000001","line_url":"/filing/0001426812-15-000001#line-6","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":null,"owner_name":"SPCH, LLC; Midler Andrew R","owner_display_name":"SPCH, LLC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":9.0015,"price_display":"9.00","price_state":"stated","total_value":9001.5,"total_display":"9,001.50","total_whole":"9,002","shares_owned_after":79238.0,"shares_owned_after_display":"79,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-07-29","filed_date":"2015-02-12","scope":"insider"},{"id":8258255,"accession":"0001426812-15-000001","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001426812-15-000001","line_url":"/filing/0001426812-15-000001#line-5","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":null,"owner_name":"SPCH, LLC; Midler Andrew R","owner_display_name":"SPCH, LLC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":9.1,"price_display":"9.10","price_state":"stated","total_value":9100.0,"total_display":"9,100.00","total_whole":"9,100","shares_owned_after":79238.0,"shares_owned_after_display":"79,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-07-24","filed_date":"2015-02-12","scope":"insider"},{"id":8258251,"accession":"0001426812-15-000001","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001426812-15-000001","line_url":"/filing/0001426812-15-000001#line-4","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":null,"owner_name":"SPCH, LLC; Midler Andrew R","owner_display_name":"SPCH, LLC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":12.5478,"price_display":"12.55","price_state":"stated","total_value":50191.2,"total_display":"50,191.20","total_whole":"50,191","shares_owned_after":79238.0,"shares_owned_after_display":"79,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-07-02","filed_date":"2015-02-12","scope":"insider"},{"id":8258248,"accession":"0001426812-15-000001","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001426812-15-000001","line_url":"/filing/0001426812-15-000001#line-3","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":null,"owner_name":"SPCH, LLC; Midler Andrew R","owner_display_name":"SPCH, LLC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":13.1108,"price_display":"13.11","price_state":"stated","total_value":13110.8,"total_display":"13,110.80","total_whole":"13,111","shares_owned_after":79238.0,"shares_owned_after_display":"79,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-06-24","filed_date":"2015-02-12","scope":"insider"},{"id":8258244,"accession":"0001426812-15-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001426812-15-000001","line_url":"/filing/0001426812-15-000001#line-2","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":null,"owner_name":"SPCH, LLC; Midler Andrew R","owner_display_name":"SPCH, LLC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":12.5,"price_display":"12.50","price_state":"stated","total_value":12500.0,"total_display":"12,500.00","total_whole":"12,500","shares_owned_after":79238.0,"shares_owned_after_display":"79,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-07","filed_date":"2015-02-12","scope":"insider"},{"id":8258239,"accession":"0001426812-15-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001426812-15-000001","line_url":"/filing/0001426812-15-000001#line-1","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":null,"owner_name":"SPCH, LLC; Midler Andrew R","owner_display_name":"SPCH, LLC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.0638,"price_display":"12.06","price_state":"stated","total_value":24127.6,"total_display":"24,127.60","total_whole":"24,128","shares_owned_after":79238.0,"shares_owned_after_display":"79,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-29","filed_date":"2015-02-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000818033","name":"HERON THERAPEUTICS, INC. /DE/","url":"/issuer/0000818033","role":"Other","n_filings":1,"first_seen":"2015-02-12","last_seen":"2015-02-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001558362","retrieved_at":"2026-08-22T21:39:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}